{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:06:19Z","timestamp":1780085179139,"version":"3.54.0"},"reference-count":24,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,2,18]]},"DOI":"10.1248\/bpb.b25-00474","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:09:20Z","timestamp":1771366160000},"page":"335-340","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factor of Persistent Hypotension Associated with 5-Aminolevulinic Acid: A Single-Institution Retrospective Study"],"prefix":"10.1248","volume":"49","author":[{"given":"Naoto","family":"Okada","sequence":"first","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kimura","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Tamura","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Ochi","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yamaguchi University Hospital, Yamaguchi 755\u20138505, Japan"},{"name":"Clinical Pharmacology, Yamaguchi University Graduate School of Medicine, Yamaguchi 755\u20138505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Casas A. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. <i>Cancer Lett.<\/i>, <b>490<\/b>, 165\u2013173 (2020).","DOI":"10.1016\/j.canlet.2020.06.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Steinbach P, Kriegmair M, Baumgartner R, Hofst\u00e4dter F, Kn\u00fcchel R. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. <i>Urology<\/i>, <b>44<\/b>, 676\u2013681 (1994).","DOI":"10.1016\/S0090-4295(94)80203-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nakai Y, Inoue K, Tsuzuki T, Shimamoto T, Shuin T, Nagao K, Matsuyama H, Oyama M, Furuse H, Ozono S, Miyake M, Fujimoto K. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study. <i>Int. J. Urol.<\/i>, <b>25<\/b>, 723\u2013729 (2018).","DOI":"10.1111\/iju.13718"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kobayashi K, Matsuyama H, Oka S, Nakamura K, Misumi T, Hiroyoshi T, Ito H, Isoyama N, Hirata H, Matsumoto H, Shiraishi K. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>41<\/b>, 103294 (2023).","DOI":"10.1016\/j.pdpdt.2023.103294"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fukuhara H, Yamamoto S, Karashima T, Inoue K. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy. <i>Int. J. Clin. Oncol.<\/i>, <b>26<\/b>, 18\u201325 (2021).","DOI":"10.1007\/s10147-020-01704-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nakatani S, Ida M, Wang X, Naito Y, Kawaguchi M. Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>34<\/b>, 102342 (2021).","DOI":"10.1016\/j.pdpdt.2021.102342"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II\/III study. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>12<\/b>, 193\u2013200 (2015).","DOI":"10.1016\/j.pdpdt.2015.03.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Miyakawa J, Kawai T, Makino K, Akiyama Y, Yamada Y, Nakamura M, Sato Y, Yamada D, Suzuki M, Kume H. Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>33<\/b>, 102179 (2021).","DOI":"10.1016\/j.pdpdt.2021.102179"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Fukuhara H, Nohara T, Nishimoto K, Hatakeyama Y, Hyodo Y, Okuhara Y, Oyama M, Mizokami A, Inoue K, Matsuyama H. Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study. <i>BMC Cancer<\/i>, <b>21<\/b>, 1223 (2021).","DOI":"10.1186\/s12885-021-08976-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yatabe T, Karashima T, Kume M, Kawanishi Y, Fukuhara H, Ueba T, Inoue K, Okuhara Y, Yokoyama M. Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study. <i>JA Clin. Rep.<\/i>, <b>6<\/b>, 35 (2020).","DOI":"10.1186\/s40981-020-00340-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Miyazaki T, Taguchi S, Obata N, Mizobuchi S. Severe hypotension and postoperative cardiac arrest caused by 5-aminolevulinic acid: a case report. <i>J. Med. Case Rep.<\/i>, <b>18<\/b>, 264 (2024).","DOI":"10.1186\/s13256-024-04589-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Owada G, Nishizawa H, Matoyama Y, Watanabe E, Mitsuda K, Kaneko N, Kimura Y, Nanao T, Fujimoto J. Effect of arginine vasopressin on intraoperative hypotension caused by oral administration of 5-aminolevulinic acid. <i>Case Rep. Anesthesiol.<\/i>, <b>2023<\/b>, 1745373 (2023).","DOI":"10.1155\/2023\/1745373"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mingone CJ, Gupte SA, Chow JL, Ahmad M, Abraham NG, Wolin MS. Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, <b>291<\/b>, L337\u2013L344 (2006).","DOI":"10.1152\/ajplung.00482.2005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dalton JT, Yates CR, Yin D, Straughn A, Marcus SL, Golub AL, Meyer MC. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>301<\/b>, 507\u2013512 (2002).","DOI":"10.1124\/jpet.301.2.507"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kida T, Kobashi T, Usuda Y, Kobayashi K, Sumitomo M. Severe and prolonged hypotension after oral 5-aminolevulinic acid administration in a patient with end-stage renal disease undergoing transurethral resection of a bladder tumor: a case report. <i>A A Pract.<\/i>, <b>14<\/b>, 12\u201314 (2020).","DOI":"10.1213\/XAA.0000000000001128"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Shiratori T, Hotta K, Satoh M, Kamigaito T, Goto M. Higher hematocrit level associated with higher 5-aminolevulinic acid-induced perioperative blood pressure change. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>38<\/b>, 102821 (2022).","DOI":"10.1016\/j.pdpdt.2022.102821"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kilgannon JH, Roberts BW, Reihl LR, Chansky ME, Jones AE, Dellinger RP, Parrillo JE, Trzeciak S. Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. <i>Resuscitation<\/i>, <b>79<\/b>, 410\u2013416 (2008).","DOI":"10.1016\/j.resuscitation.2008.07.019"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kondo Y, Mihara T, Yoshikawa N, Echigo N, Nagamine Y, Goto T. Preoperative antihypertensives and hypotension during bladder tumor resection with oral 5-aminolevulinic acid administration. <i>PLOS ONE<\/i>, <b>20<\/b>, e0319413 (2025).","DOI":"10.1371\/journal.pone.0319413"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Okabe Y, Fukuhara Y, Matsuoka W, Nakamura N, Matsuzaki H, Miyazaki T, Gunge N, Tominaga K, Tsubouchi K, Tachibana M, Nakagawa C, Yamazaki F, Haga N. Identification of risk factors associated with oral 5-aminolevulinic acid induced adverse events in photodynamic diagnosis-transurethral resection of bladder tumor. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>49<\/b>, 104291 (2024).","DOI":"10.1016\/j.pdpdt.2024.104291"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. <i>Am. J. Kidney Dis.<\/i>, <b>53<\/b>, 982\u2013992 (2009).","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Morisawa S, Jobu K, Ishida T, Kawada K, Fukuda H, Kawanishi Y, Nakayama T, Yamamoto S, Tamura N, Takemura M, Kagimoto N, Ohta T, Masahira N, Fukuhara H, Ogura SI, Ueba T, Inoue K, Miyamura M. Association of 5-aminolevulinic acid with intraoperative hypotension in malignant glioma surgery. <i>Photodiagnosis Photodyn. Ther.<\/i>, <b>37<\/b>, 102657 (2022).","DOI":"10.1016\/j.pdpdt.2021.102657"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. <i>Nitric Oxide<\/i>, <b>21<\/b>, 149\u2013156 (2009).","DOI":"10.1016\/j.niox.2009.07.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sagawa N, Marcum ZA, Boudreau RM, Hanlon JT, Albert SM, O\u2019Hare C, Satterfield S, Schwartz AV, Vinik AI, Cauley JA, Harris TB, Newman AB, Strotmeyer ES. Low blood pressure levels for fall injuries in older adults: the health, aging and body composition study. <i>Eur. J. Ageing<\/i>, <b>15<\/b>, 321\u2013330 (2018).","DOI":"10.1007\/s10433-017-0449-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shimada T, Pu X, Kutlu Yalcin E, Cohen B, Bravo M, Mascha EJ, Sessler DI, Turan A. Association between postoperative hypotension and acute kidney injury after noncardiac surgery: a historical cohort analysis. <i>Can. J. Anaesth.<\/i>, <b>70<\/b>, 1892\u20131900 (2023).","DOI":"10.1007\/s12630-023-02601-4"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00474\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:26:15Z","timestamp":1771644375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/2\/49_b25-00474\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00474","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"b25-00474"}}